Lymphostin (LK6-A), a novel immunosuppressant from Streptomyces sp. KY11783: Taxonomy of the producing organism, fermentation, isolation and biological activities

Journal of Antibiotics

Volumn 50, Issue 7, 1997, Pages 537-542

  Nagata, Hiroyuki ^a   Ochiai, Keiko ^a   Aotani, Yumiko ^a   Ando, Katsuhiko ^a   Yoshida, Mayumi ^a   Takahashi, Isami ^a   Tamaoki, Tatsuya ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LK6 A; LYMPHOCYTE ENZYME; LYMPHOSTIN; PHOSPHOTRANSFERASE; POLYMER; RESIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; FERMENTATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STREPTOMYCES; TAXONOMY;

EID: 0030825807     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.50.537     Document Type: Article

References (25)

1. WEIBLATT, M. E.; J. S. COBLYN, P. A. FRASER, R. J. ANDERSON, J. SPRAGG, D. E. TRENTHAM & K. F. AUSTEN: Cyclosporin A treatment of refractory rheumatoid arthritis. Arthritis Rheum. 30: 11-17, 1987
2. INAMURA, N.; M. HASHIMOTO, K. NAKAHARA, H. AOKI, I. YAMAGUCHI & M. KOHSAKA: Immunosuppressive effect of FK506 on collagen-induced arthritis in rats. Clin. Immunol. Immunother. 46: 82-90, 1988
3. NUSSENBLATT, R. B.; A. H. ROOK, W. B. WACKER, A. G. PALEATINE, I. SCHER & I. GERY: Treatment of intraocular inflammatory diseases with cyclosporin A. Lancet 1983-II: 235-238, 1983
4. KAWASHIMA, H.; Y. FUJINO & M. MOCHIZUKI: Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Invest. Ophthalmol. 29: 1265-1271, 1988
5. STILLER, C. R.; J. DUPRE, M. GENT, M. R. JENNER, P. A. KEOWN, A. LAUPACIS, R. MARTELL, N. W. RODGER, B. V. GRAFFENRIED & B. M. J. WOLFE: Effect of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223: 1362-1367, 1984
6. MURASE, N.; I. LIEBERMAN, M. A. NALESNIK, D. H. MINTZ, S. TODO, A. L. DRASH & T. E. STARZL: Effect of FK506 on spontaneous diabetes in BB rats. Diabetes 39: 1584-1586, 1990
7. LIU, J.; J. D. FARMER, Jr., W. S. LANE, J. FRIEDMAN, I. WEISSMAN & S. L. SCHREIBER: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815, 1991
8. lck in T cell signaling and thymocyte development. Advances in Immunology 56: 151-178, 1994
9. lck. Cell 55: 301-308, 1988
10. IWASHIMA, M.; B. A. IRVING, N. S. C. van OERS, A. C. CHAN & A. WEISS: Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263: 1136-1139, 1994
11. STRAUS, D. B. & A. WEISS: Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70: 585-593, 1992
12. lck. Nature 357: 161-167, 1992
13. lck do not express significant antiviral effector functions. J. Immunol. 151: 699-706, 1993
14. lck. Eur. J. Immunol. 25: 3155-3159, 1995
15. TAMAOKI, T.; H. NAGATA, I. TAKAHASHI, M. YOSHIDA, Y. AOTANI, K. ANDO & K. OCHIAI (Kyowa Hakko Kogyo Co., Ltd.): Pyrrolo(4,3,2-de)quinoline derivative. JP 250276/95, Sep. 28, 1995
16. AOTANI, Y.; H. NAGATA & M. YOSHIDA: Lymphostin (LK6-A), a novel immunosuppressant from Streptomyces sp. KY11783. Structural elucidation. J. Antibiotics 50: 543-545, 1997
17. SHIRLING, E. B. & D. GOTTLIEB: Methods for characterization of Streptomyces species. Int. J. Syst. Bacteriol. 16: 313-340, 1966
18. In Color Harmony Manual, 4th Ed., Container Corporation of America, Chicago, 1958
19. HASEGAWA, T.; M. TAKIZAWA & S. TANIDA: A rapid analysis for chemical grouping of aerobic actinomycetes. J. Gen. Appl. Microbiol., 29: 319-322, 1983
20. CUSHMAN, M.; D. NAGARATHNAM, D. L. BURG & R. L. GEAHLEN: Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues. J. Med. Chem. 34: 798-806, 1991
21. c-src. Biochim. Biophys. Acta 1248: 50-56, 1995
22. WEBB, S.; C. MORRIS & J. SPRENT: Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63: 1249-1256, 1990
23. lck. J. Med. Chem. 36: 425-432, 1993
24. SMYTH, M. S.; I. STEFANOVA, F. HARTMANN, I. D. HORAK, N. OSHEROV, A. LEVITZKI & T. R. BURKE, Jr.: Non-amine based analogues of lavendustin A as protein-tyrosine kinase inhibitors. J. Med. Chem. 36: 3010-3014, 1993
25. HANKE, J. H.; J. P. GARDNER, R. L. DOW, P. S. CHANGELIAN, W. H. BRISSETTE, E. J. WERINGER, B. A. POLLOK & P. A. CONNELLY: Discovery of a novel, potent, and src family-selective tyrosine kinase inhibitor. J. Biol. Chem. 271: 695-701, 1996